NEIL A. CAPRETTO, D.O., F.A.S.A.M.

Size: px
Start display at page:

Download "NEIL A. CAPRETTO, D.O., F.A.S.A.M. ncapretto@gatewayrehab.org www.gatewayrehab.org"

Transcription

1 NEIL A. CAPRETTO, D.O., F.A.S.A.M. PROFESSIONAL EXPERIENCE Gateway Rehabilitation Center, Aliquippa, PA Medical Director. January 1998 to Present. Director of Treatment. October 1989 to December Duties include: Supervision of the Therapy Staff and providing psychiatric evaluation and treatment to select patients. The Medical Center, Beaver, PA. Psychiatric Consultant. October 1989 to Present. The Medical Center of Beaver, Beaver, PA. Medical Director, Senior Psychiatric Unit. April October 1989 Psychiatric Associates of Beaver Valley, Rochester, PA. President. January 1988 October This professional corporation included five full-time and three part-time psychiatrists. Community Mental Health of Beaver County, Rochester, PA. Medical Director. October 1986 October Staff Psychiatrist. July October 1989 Duties included the clinical supervision of approximately 70 staff members as well as work on active inpatient and outpatient units. Consultation-Liaison work with 500 bed Medical Center of Beaver and coverage for emergency services and adolescent inpatients are included in these duties. Other responsibilities included coverage for eating disorder unit and consultation work with Gateway Rehabilitation Center. Dixmont and Mayview State Hospitals, Pittsburgh, PA. Psychiatric Physician In-Charge, Deaf Unit. January 1983 June LICENSURE State of Pennsylvania #OS L Certified by the American Board of Psychiatry and Neurology, November 1986 Certified by the American Board of Psychiatry and Neurology with added qualification in Addiction Psychiatry, March Recertification March 2003 Certified by the American Society of Addiction Medicine, December Recertification November 2002

2 LICENSURE (cont d) Certified by the American Society of Addiction Medicine as a Medical Review Officer, November 2003 Fellow American Society of Addiction Medicine, January 1997 Certified by the American Board of Addiction Medicine, 2010 EDUCATION St. Francis General Hospital, Pittsburgh, PA. July June Chief Resident during fourth year of training in psychiatry. Philadelphia College of Osteopathic Medicine, Philadelphia, PA. Class of Allegheny College, Meadville, PA. Class of Bachelor of Science - Major in Biology and English; Minor in Writing. Kiski Area High School, Vandergrift, PA. Class of 1973 ACTIVITIES AND AWARDS Professional: Advisory Board of the Pennsylvania Medical Society's Physicians Health Program Board of Directors of the Pennsylvania Medical Society's Physicians Health Program , Secretary of the Pennsylvania Society of Addiction Medicine Board of Directors of Pennsylvania Society of Addiction Medicine Present. Vice President, Pennsylvania Society of Addiction Medicine, 2002 Present. Board of Directors, Beaver County Mental Health/Mental Retardation Vice President of the Board of Directors , President of the Board of Directors , Re-appointed to the Board Member, American Society of Addiction Medicine. Member of A.S.A.M.'s Task Force on Addiction Medicine in the 21st Century. Member of the American Academy of Psychiatrists in Alcoholism and Addiction. Past Vice-President, Residents' Association, St. Francis General Hospital, Member, Outreach to Professional Advisory Committee, Al-Anon World Service Headquarters, 2006 Present. Medical School: Scholarship Recipient , Addison Gibson Foundation, Pittsburgh, PA. Scholarship Recipient , Citizens General Hospital, New Kensington, PA. College: Alden Scholar Award for High Academic Achievement Elected member of the Student/Faculty Pre-Health Advisory Committee Four-year letterman in track; three-year letterman in football Reporter for "Campus," the college newspaper Vice President, Inter-fraternity Council (member, Phi Delta Theta Fraternity) High School: National Honor Society President, Student Council Varsity Club with four years of track and football.

3 Neil A. Capretto D.O., F.A.S.A.M. 1. Medical Director at Gateway Rehabilitation Center since 1998 and full time Psychiatrist with Gateway since Served on the Board of Directors of the Pennsylvania Medical Society s Physicians Health Program from and Past Chief of Medical Staff of the Beaver County Community Mental Health Center and the first Medical Director of Psychiatry at the Medical Center, Beaver, PA. 4. He has also been used on numerous occasions as a consultant for local media, The National Football League, has served as a consultant for ABC and NBC national broadcast news, New York Times and People Magazine, Lifetime TV Network. 5. Member, Outreach to Professional Advisory Committee, Al-Anon World Service Headquarters, 2006 Present. 6. Serve on the Board of Directors of the Pennsylvania Society of Addiction Medicine, 1992 Present. 7. Serve on the Allegheny County Overdose Prevention Coalition Executive Committee, 2009 Present.

4 NEIL A. CAPRETTO, D.O., F.A.S.A.M. MEDICAL DIRECTOR GATEWAY REHABILITATION CENTER 1. Is smoke a healthy, scientific route of administration? 2. Is it in the public interest to approve a drug, especially a widely abused drug, by ballot initiative or legislative action? How anyone particularly any physician could answer yes to either question is baffling 1

5 It is important to distinguish between cannabinoids and crude marijuana: A medicine that is a purified chemical (sometimes from a plant or a synthetic analogue) in controlled doses A plant itself If there is any future for marijuana as a medicine, it lies in its isolated components, the cannabinoids and their synthetic derivatives. Isolated cannabinoids will provide more reliable effects than crude plant mixtures. Therefore, the purpose of clinical trials of smoked marijuana would not be to develop marijuana as a licensed drug but rather to serve as a first step toward the development of nonsmoked rapidonset cannabinoid delivery systems. In summary, there are many reasons to worry that for people who might choose to use marijuana as medicine and especially those who smoke it the drug could actually add to their health problems. Proof that habitual marijuana smoking does or does not lead to respiratory cancer awaits the results of extensive, carefully designed epidemiological studies. In the meantime it appears that, for people with chronic medical disorders or those with compromised respiratory or immune systems, smoking marijuana is likely to do at risk of cardiovascular disease, pregnant women, and couples trying to conceive, the marijuana appear to exceed the potential medical benefits. 2

6 Cannabis contains more than 400 chemicals, including ~66 cannabinoids Delta 9 tetrahydrocannabinol (THC) is the major psychoactive component, first isolated in 1964 (Hirst et al., 1998) Marijuana generally refers to the dried flowers, leaves, and stems of the female cannabis plant contains 3% to 22% THC Hash oil is a mix of essential oils from seeds and resins extracted from cannabis high proportion of cannabinoids (ranging from 40 to 90% THC) used in a variety of cannabis foods 3

7 Hashish or Hash is a concentrated resin (hydrocarbon secretion) produced from the flowers of the female cannabis plant can contain up to 70% THC Inhaled THC: peak plasma levels achieved within 10 minutes Intoxication effects last approximately 2 4 hours. Oral THC: 2 3 x the time duration to achieve peak plasma levels (0.5 2 hours) About 1/4 to 1/3 as potent as compared with inhalation Effects can last 5 6 hours because of continued GI absorption Metabolized by the hepatic p450 system, with 1/3 of THC is eliminated through urination and 2/3 eliminated through fecal excretion. High lipid solubility accumulates in fatty tissues, such as adipose, brain, pulmonary surfactant, and breast milk UDS can be positive for up to 10 days Body Tissue samples can be positive for up to 30 days 4

8 CB 1 receptors: Located on presynaptic glutamatergic and GABAergic neurons in the Ventral Tegmental Area, and act to influence dopamine, which is believed to activate the reward pathway (Maldonado et al., 2006). Very few cannabinoid receptors are located in the brain stem, which may explain the lack of association respiratory depression (Tsou et al., 1998). Highly expressed in the areas involved in pain modulation, including the periaqueductal gray matter, and the dorsal horn of the spinal cord. (Tsou et al., 1997; Farquhar Smith et al., 2000) Also discovered in peripheral tissues including the cardiac, liver, respiratory, and GI system, and have been found to be involved in regulation of appetite stimulation, fat accumulation, and lipid and glucose metabolism (Osei Hyiama et al., 2005) CB 2 receptors: Closely linked with cells of the immune system, predominantly the spleen and macrophages (Kumar RN, et al., 2008) Commonly associated with: altered conscious perception euphoria, feelings of well being relaxation or stress reduction increased appreciation of humor, music, and the arts metacognition, introspection increased sensuality and libido paranoia, anxiety, panic attacks increased appetite At higher doses: Altered body image Auditory and visual hallucinations, illusions Ataxia, incoordination Dysarthria Short term memory, attention deficits Impaired motor skills, decreased reaction time 5

9 Eye Decreased intraocular pressure Cardiovascular System Heart rate: tachycardia with acute use, bradycardia with chronic use Peripheral circulation: vasodilatation, conjunctival redness, postural hypotension Cardiac Output: increased output and myocardial oxygen demand Cerebral blood flow: increases with acute use, decreased with chronic use Pulmonary System Ventilation: stimulated by small doses, depressed by larger doses Bronchodilation: irritant, coughing Airway Obstruction: seen with chronic smoking Immune System Impaired bactericidal activity of macrophages in lung and spleen Reproductive System Decreased sperm count, sperm motility; supression of ovulation Marijuana has NOT been approved by the US FDA Currently, there are 2 FDA approved cannabinoid pharmaceuticals available by prescription: 1. Dronabinol (Marinol) Schedule III drug, indicated for the nausea and vomiting associated with cancer chemotherapy 2. Nabilone (Casemet) Schedule II drug, indicated for anorexia and weight loss in HIV/AIDS patients and Nausea and vomiting associated with cancer chemotherapy Outside of the USA, Sativex (a Cannabis extract) has been approved for use in Multiple Sclerosis Machado et al., 2008, European Journal of Cancer Care Systematic Review of 30 studies involving patients undergoing chemotherapy for various cancers Dronabinol vs. Neuroleptics ( 5 studies) = The cannabinoid dronabinol had an anti emetic efficacy superior to neuroleptics for cancer patients receiving chemotherapy. Nabilone vs. Neuroleptics (6 studies) & Lenonvantradol vs. Neuroletpics (2 studies) = No statistically significant difference, a clinically significant difference in favor of nabilone or Levonantradol was observed. Patient preference for Cannabinoid vs. Other drug (18 studies) = Patients showed clear preference for cannabinoids as anti emetic medication Regarding medical safety: 5% of patients reported paranoid delusions, 6% reported AVH, 13% reported dysphoria as adverse SE. euphoria and sedation viewed as beneficial, not recorded as adverse SE 6

10 Campbell et al, 2001, BMJ 9 total trials examining cancer pain, chronic non malignant pain and post op pain Compared cannabinoid treatment with codeine Conclusions: Cannabinoids were not efficacious in post op pain Cannabinoid treatment no more effective than codeine in pain control CNS side effects limited cannabinoid treatment Martin Sanchez et al, 2009, Pain Medicine Systematic Review and meta analysis of 18 trials patients with chronic pain (of various etiologies), Received cannabinioid treatment or placebo Conclusion: There is reported efficacy in chronic pain treatment High number of serious adverse SE in the short term use Risks out weight Benefits Few controlled studies were found with objective data on the use of cannabinoids or marijuana for appetite stimulation. Strasser et al., 2006, Journal of Clinical Oncology Cannabis vs placebo in 164 patients with Cancer Related Anorexia Cachexia Syndrome Conclusion: No difference in appetite or weight gain among the patient groups Haney et al. (2005, 2007) demonstrate that both smoked cannabis (up to 3.9% THC) and oral Dronabinol (up to 10 mg daily) stimulate appetite and weight gain in patients with HIV wasting syndrome Several anecdotal reports, few published case controlled studies Merrit et al., 1980, trial of 18 glaucoma patients smoked a marijuana cigarette (~ 2% THC). significant reduction in IOP Adverse SE including various sensory alterations (100% of the cases), tachycardia and palpitations (44% of the cases) and postural hypotension (28%). Merrit et al., 1982, clinical trial with 8 patients using eye drops containing 0.01%, 0.05%, or 0.1% THC significant reduction in IOP with 0.05 and 0.1% topical solutions of THC 0.1% topical solution of THC induced a mild hypotension no psychotropic effects were observed The Institute of Medicine deemed the use of cannabis in glaucoma as unsatisfactory with limited beneficial effects: short term action (a few hours) high incidence of undesirable central and peripheral reactions, especially in the elderly Can use other more effective and less toxic drugs 7

11 Conclusions: Cannabinoids have not been shown to improve objective findings in MS Cannabinoids are associated with subjective improvement in MS symptoms Intoxication increases risks of MVA (Hall et al. 2009) Reduced hippocampal and amygdala volumes in chronic heavy users (Yucel et al., 2008) Subtle cognitive impairment with frequent and longterm cannabis use (Solowij et al., 2002) - Deficits in verbal learning, memory, attention - Unclear if function recovers after cessation of Cannabis 8

12 Risk for MI is 4.8 times increased in the hour after cannabis use (Mittleman et al., 2001) Smoking cannabis provokes angina (Gottschalk et al. 1977) Patients with COPD report more symptoms (Tetrault et al., 2007) Dose response relation between frequency smoked cannabis and lung cancer risk (Aldington et al, 2008) Increased respiratory infections in cannabis smokers (Tashkin et al., 2002) Reduced Birth weight (Fergusson et al., 2002) Mild developmental abnormalities (Fried et al., 2001) Postnatal Behavioral Effects (Huizink et al., 2006) _ Poorer performance on memory and verbal skills at 3 years old _ Increased delinquency by 10 years old _ Cannot control for confounding factors A typical joint contains <10 mg of THC, and >1000 would need to be smoked to reach toxic levels (from Merck Index LD 50 of THC) No clearly documented case of death caused by cannabis intoxication alone. 9

13 (Kandel, 2002) Cannabis users are more likely to later use Rx opiates, heroin, and cocaine The earlier the age at which a young person uses cannabis, the more likely they are to use Rx opiates, heroin, and cocaine Several studies suggest that cannabis is an independent risk factor for the development of chronic psychotic disorders - 13% of schizophrenia cases could be averted if cannabis use was prevented (Zammit et al., 2002) Increased rates of depression and anxiety? Increased risk of suicide attempts in adolescents if Cannabis use disorder present (Beautrais et al., 1999) In Australian National Survey of Mental Health and Well Being, 2001 Major dep 6% among nonusers of cannabis v. 14% among those who met cannabis dep. Rey et al in Australian teens Those ever used cannabis were 3 times depression v. never used Fergusson et al 1997, N=1265 prospective from birth in New Zealand, unpublished 15 16yo used none v 1 9 times v 10+ times 11% v 18% v 36% met mood disorder criteria 20 21yo, used at least weekly 30% dep v 15% not using 10

14 Teens who use marijuana have 8 times higher rate of suicidal ideation than nonmarijuana users and a 16% times higher rate of suicide attempts. Loss of interest in things in general: apathy and passivity Loss of desire to work, loss of work performance concern resulting in lost productivity Loss of energy and fatigability Moodiness and irritability Impaired concentration Lack of concern for personal appearance and hygiene Lifestyle that prioritizes getting and using it For dependent people, more immediate psychotic symptoms twice the non users Possible high vulnerability population can precipitate psychosis more with heavy use of cannabis More positive symptoms with cannabis Fewer negative symptoms with cannabis in some studies Most case reports remitted quickly when psychotic sx 11

15 General population: 1.0% Use of marijuana 10 times: 2.1% Use of marijuana 80 times: 2.9% PHARMACOLOGY marijuana is fat soluble effects may persist or reoccur for hours the ability to drive a car or a plane, other motor performance tasks, alertness and the ability to concentrate may be affected for hours to days Marijuana and Driving 65% of heavy drinkers also smoke marijuana marijuana appears in urine and blood 3 5 times more frequently in fatal driving accidents than in the general population. (SAMSHA, 1999) marijuana, drive slower; alcohol, drive faster; low dose marijuana + low dose alcohol (.04 BAC) =.09 BAC moderate marijuana + low dose alcohol = >.12 BAC high marijuana + low dose alcohol = inability to stand impairment lasted 3 hours Source: James O Hanlon, Ph.D. Institute of Human Psychopharmacology/The Netherlands (2000). 12

16 MARIJUANA AND DRIVING impairment dose related 60% failed field sobriety test 2 1/2 hours after moderate smoking impairment documented 3 8 hours later (Hollister, 1986) low amounts, diminished ability to perceive and respond to changes on the road did not make appropriate speed adjustments induces drowsiness and impairs judgment (Mathias, 1996) with alcohol, performance worse (SAMHSA/NHTSA) Marijuana use among teens rose in 2011 for the fourth straight year Daily marijuana use is now at 30 year peak high among high school seniors Synthetic marijuana, K2, Spice, used by 11.4% of high school seniors in prior 12 months One possible explanation for the resurgence in marijuana use is that in recent years fewer teens repeat seeing much danger associated with its use, even with regular use. Perceived risk of marijuana by teens has been falling rather sharply over the past five years Teens disapproval of marijuana use also has fallen over the past three to four years, suggesting a lowering of peer norms against use Monitoring The Future 13

17 4.9% If parents strongly disapprove of marijuana 26.9% If parents do not strongly disapprove Studying the biology of cannabinoids may produce future medications and therapies FDA approved Marinol, synthetic THC, available since 1985 FDA approved Cesamet, available since 2006 We may soon have Sativex 1:1 ratio of THC and Cannabidiol (CBD) Approved in the UK and Spain CBD is often bred out of modern herbal cannabis because it interferes with the high Investigational New Drug Application (IND) Preclinical animal trial showing drug is reasonably safe Clinical Trials Phase I: Determine most frequent side effects, metabolism and excretion Healthy volunteers Phase II: Effectiveness and safety and short term side effects Phase III: Large scale studies gather more information about safety and effectiveness and study different populations and dosages and use with other drugs New Drug Application (NDA) Evaluation of all animal and human data and manufacturing process 14

18 Cannabis, cannabis based products, and cannabis delivery devices should be subject to the same standards that are applicable to other prescription medications and medical devices Medical products should not be distributed or used unless and until they have received marketing approval by the Food and Drug Administration (FDA) Rejects smoking as a means of drug delivery because it is not safe Recognizes the supremacy of federal regulatory standards for drug approval and distribution States should not enact more permissive regulatory standards Objects to state violation of the federal medication approval process Rejects approval of medicines through states and local ballot initiatives Recommends its members and other physician organizations reject responsibility for providing access to cannabis and cannabisbased products unless they receive FDA approval 15

19 The practice of medicine is increasingly evidencebased; yet some physicians are willing to consider recommending cannabis to their patient, despite the fact that they lack even the most rudimentary information about the material currently being consumed by patients including: composition, quality and dose and no controlled studies provide information on its benefit and safety of it s use in chronic medical conditions All cannabis based and cannabinoid medications should be subjected to the rigorous scrutiny of the FDA regulator process that provides important protections for patients, making medications available only when they: 1. Are standardized by identity, purity, potency and quality 2. Are accompanied by adequate directions for use in the approved medical indication 3. Have risk/benefit profiles that have been defined in well controlled clinical trials (ASAM, Sept 2010) Cannabis based medications must meet the exacting standards that we apply to other prescriptions medications Any use of a controlled substance must meet high standards to protect the patient and the public; the approval of medical marijuana does not meet this standard 16

20 NEIL A. CAPRETTO, D.O., F.A.S.A.M. MEDICAL DIRECTOR GATEWAY REHABILITATION CENTER 100 MOFFETT RUN ROAD ALIQUIPPA, PA , x

National Institute on Drug Abuse National Institutes of Health. Marijuana. Facts

National Institute on Drug Abuse National Institutes of Health. Marijuana. Facts National Institute on Drug Abuse National Institutes of Health Marijuana for Teens1 Facts Contents Letter to Teens Letter to teens Did you know that teen marijuana use has dropped dramatically since the

More information

national institute on drug abuse national institutes of health Revised

national institute on drug abuse national institutes of health Revised national institute on drug abuse national institutes of health Revised Contents... What is marijuana? 2 How is marijuana used? 4 How long does marijuana stay in the user s body? 5 How many teens smoke

More information

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents

Teen Misuse and Abuse of Alcohol and Prescription Drugs. Information for Parents Teen Misuse and Abuse of Alcohol and Prescription Drugs Information for Parents Terminology Misuse: Using a drug in a way in which it was not intended Example: Using a higher dose of medication than was

More information

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?

Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain? Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears

More information

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.

Like cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive. Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.

More information

DRUGS OF ABUSE CLASSIFICATION AND EFFECTS

DRUGS OF ABUSE CLASSIFICATION AND EFFECTS Drug and Drug use DRUGS OF ABUSE CLASSIFICATION AND EFFECTS A pharmaceutical preparation or a naturally occurring substance used primarily to bring about a change in the existing process or state (physiological,

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT

Considerations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA

More information

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?

Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health? Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown

More information

Policies and Procedures VI-4, p.1 Reviewed/Revised January 2014 SUBSTANCE ABUSE PREVENTION

Policies and Procedures VI-4, p.1 Reviewed/Revised January 2014 SUBSTANCE ABUSE PREVENTION Policies and Procedures VI-4, p.1 1. GENERAL Unless a standard of conduct is specifically limited to a particular group, the standards apply to all faculty and staff. This policy is not intended to affect

More information

California Society of Addiction Medicine (CSAM) Consumer Q&As

California Society of Addiction Medicine (CSAM) Consumer Q&As C o n s u m e r Q & A 1 California Society of Addiction Medicine (CSAM) Consumer Q&As Q: Is addiction a disease? A: Addiction is a chronic disorder, like heart disease or diabetes. A chronic disorder is

More information

BLOOD ALCOHOL CONCENTRATION

BLOOD ALCOHOL CONCENTRATION BLOOD ALCOHOL CONCENTRATION Blood Alcohol Concentration (BAC) is the amount of alcohol in the bloodstream. It is measured in percentages. For instance, having a BAC of 0.10 percent means that a person

More information

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,

More information

Parents Need to Know. Revised. National Institutes of Health. National Institute on Drug Abuse

Parents Need to Know. Revised. National Institutes of Health. National Institute on Drug Abuse Marijuana: Facts Parents Need to Know Revised National Institute on Drug Abuse National Institutes of Health The human brain does not fully mature until the early twenties. Among the last areas to develop

More information

The Adolescent Cycle of Addiction

The Adolescent Cycle of Addiction 0 0 0 The Adolescent Cycle of Addiction What they are Using, Why they are Using, and How they 0 are Unique Traci Wojciechowski Regional Director of SAP 610-462-7334 0 Kelly McAdams Business Development

More information

BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013

BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013 BEHAVIORAL HEALTH AND DETOXIFICATION - MEETING DEMAND FOR SERVICES UNIVERSITY OF PITTSBURGH MEDICAL CENTER MERCY HOSPITAL Publication Year: 2013 Summary: The development of separate intake area for behavioral

More information

Metropolitan Bureau of Investigation. Narcotics - Vice - Organized Crime

Metropolitan Bureau of Investigation. Narcotics - Vice - Organized Crime Metropolitan Bureau of Investigation Narcotics - Vice - Organized Crime METROPOLITAN BUREAU of INVESTIGATION State Attorney Ninth Judicial Circuit Orange County Sheriff s Office Orlando Police Department

More information

Authorizing Dried Cannabis for Chronic Pain or Anxiety

Authorizing Dried Cannabis for Chronic Pain or Anxiety THE COLLEGE OF FAMILY PHYSICIANS OF CANADA LE COLLÈGE DES MÉDECINS DE FAMILLE DU CANADA Authorizing Dried Cannabis for Chronic Pain or Anxiety preliminary guidance September 2014 This guidance document

More information

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource

DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population

More information

Contemporary Psychiatric-Mental Health Nursing. Assessing the Effectiveness of Medications. Administering Medications

Contemporary Psychiatric-Mental Health Nursing. Assessing the Effectiveness of Medications. Administering Medications Contemporary Psychiatric-Mental Health Nursing Chapter 32 Psychopharmacologic Nursing Interventions Assessing the Effectiveness of Medications Include how well the medications are helping the client to

More information

MEDICATION GUIDE. Tranxene* (TRAN-zeen) T-TAB (clorazepate dipotassium) tablets

MEDICATION GUIDE. Tranxene* (TRAN-zeen) T-TAB (clorazepate dipotassium) tablets MEDICATION GUIDE Tranxene* (TRAN-zeen) T-TAB (clorazepate dipotassium) tablets Read this Medication Guide before you start taking TRANXENE and each time you get a refill. There may be new information.

More information

DRUG USE. 1300 136 588 ndss.com.au AND TYPE 1 DIABETES

DRUG USE. 1300 136 588 ndss.com.au AND TYPE 1 DIABETES DRUG USE AND TYPE 1 DIABETES 1300 136 588 ndss.com.au The National Diabetes Services Scheme (NDSS) is an initiative of the Australian Government administered by Diabetes Australia. Contents Topic Page

More information

OSU INSTITUTE OF TECHNOLOGY POLICY & PROCEDURES

OSU INSTITUTE OF TECHNOLOGY POLICY & PROCEDURES Drug Free Campus 1-018 ADMINISTRATION July 2014 POLICY 1.01 The Drug Free Schools and Communities Act Amendments of 1989 require an institution of higher education to certify to the U.S. Department of

More information

Behavioral Health Medical Necessity Criteria

Behavioral Health Medical Necessity Criteria Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett

More information

Schizoaffective Disorder

Schizoaffective Disorder FACT SHEET 10 What Is? Schizoaffective disorder is a psychiatric disorder that affects about 0.5 percent of the population (one person in every two hundred). Similar to schizophrenia, this disorder is

More information

Benzodiazepines. And Sleeping Pills. Psychological Medicine

Benzodiazepines. And Sleeping Pills. Psychological Medicine Benzodiazepines And Sleeping Pills Psychological Medicine Introduction Benzodiazepines are a type of medication prescribed by doctors for its therapeutic actions in various conditions such as stress and

More information

Behavioral Health Barometer. Oklahoma, 2014

Behavioral Health Barometer. Oklahoma, 2014 Behavioral Health Barometer Oklahoma, 2014 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283

More information

2014 FLORIDA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA

2014 FLORIDA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA 2014 FLORIDA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA SUBSTANCE ABUSE LEVEL OF CARE CLINICAL CRITERIA Overview Psychcare strives to provide quality care in the least restrictive environment. An

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

Identifying Individuals with a Dual Diagnosis and Substance Misuse

Identifying Individuals with a Dual Diagnosis and Substance Misuse Identifying Individuals with a Dual Diagnosis and Substance Misuse Presented by the Dual Diagnosis Substance Misuse Committee 1 Goal of Presentation To raise awareness To assist staff to identify individuals

More information

MENTAL HEALTH & SUBSTANCE USE

MENTAL HEALTH & SUBSTANCE USE MENTAL HEALTH & SUBSTANCE USE Essential Information for Social Workers A BASW Pocket Guide Supported by: Bedford and Luton Purpose of the guide This guide seeks to support Social Workers in their practice

More information

Maternal and Child Health Issue Brief

Maternal and Child Health Issue Brief Maternal and Child Health Issue Brief Why is substance abuse an issue among youth? December 14 8 Substance Abuse among Youth in Colorado Substance abuse among youth is defined as using alcohol, tobacco,

More information

SUBSTANCE ABUSE SCREENING

SUBSTANCE ABUSE SCREENING OVERVIEW Substance abuse in the elderly is a common problem that is frequently under- diagnosed by primary care doctors and families. Alcohol abuse is present in 10% to 15% of elderly individuals who seek

More information

This presentation was prepared by Sion Kim Harris, PhD, a research scientist with the Center for Adolescent Substance Abuse Research at Boston

This presentation was prepared by Sion Kim Harris, PhD, a research scientist with the Center for Adolescent Substance Abuse Research at Boston This presentation was prepared by Sion Kim Harris, PhD, a research scientist with the Center for Adolescent Substance Abuse Research at Boston Children s Hospital, a teaching hospital of Harvard Medical

More information

Drug and Alcohol Abuse Awareness & Prevention

Drug and Alcohol Abuse Awareness & Prevention Drug and Alcohol Abuse Awareness & Prevention Drugs and alcohol are toxic to the human body and if abused can have serious health consequences. The use or abuse of alcohol and other drugs increases the

More information

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience

Reintegration. Recovery. Medication-Assisted Treatment for Alcohol Dependence. Reintegration. Resilience Reintegration Recovery Medication-Assisted Treatment for Alcohol Dependence Reintegration Resilience 02 How do you free yourself from the stress and risks of alcohol dependence? Most people cannot do it

More information

MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA

MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA MULTIPLE SCLEROSIS AUSTRALIA MULTIPLE SCLEROSIS RESEARCH AUSTRALIA Submission to the ACT Legislative Assembly Health, Ageing, Community and Social Services Inquiry into the exposure draft of the Drugs

More information

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; 2004. NIH Publication No. 04-3769.

Source: National Institute on Alcohol Abuse and Alcoholism. Bethesda, Md: NIAAA; 2004. NIH Publication No. 04-3769. Diagnosis and Treatment of Alcohol Dependence Lon R. Hays, MD, MBA Professor and Chairman an Department of Psychiatry University of Kentucky Medical Center Defining the Standard Drink A standard drink

More information

75-09.1-08-02. Program criteria. A social detoxi cation program must provide:

75-09.1-08-02. Program criteria. A social detoxi cation program must provide: CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria

More information

POLICIES PROCEDURES AND SANCTIONS FOR ALCOHOL AND OTHER DRUGS

POLICIES PROCEDURES AND SANCTIONS FOR ALCOHOL AND OTHER DRUGS WESTCHESTER COLLEGE OF NURSING AND ALLIED HEALTH 8939 S. Sepulveda Boulevard, Suite 302 Los Angeles, CA 90045 POLICIES PROCEDURES AND SANCTIONS FOR ALCOHOL AND OTHER DRUGS Introduction WESTCHESTER COLLEGE

More information

See also www.thiswayup.org.au/clinic for an online treatment course.

See also www.thiswayup.org.au/clinic for an online treatment course. Depression What is depression? Depression is one of the common human emotional states. It is common to experience feelings of sadness and tiredness in response to life events, such as losses or disappointments.

More information

In Brief ARIZONA. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies

In Brief ARIZONA. Adolescent Behavioral Health. A Short Report from the Office of Applied Studies ARIZONA Adolescent Behavioral Health In Brief A Short Report from the Office of Applied Studies Adolescence (12 to 17 years) is a critical and vulnerable stage of human development, during which males

More information

A Growing Problem. Substance Abuse In The Eldery 1

A Growing Problem. Substance Abuse In The Eldery 1 A Growing Problem Substance Abuse In The Eldery 1 A substantial and growing percentage of older adults misuse alcohol, prescription drugs, or other substances. The number of older adults in need of substance

More information

Marijuana use among Teens

Marijuana use among Teens http://www.teendrugabuse.us/marijuana.html Marijuana use among Teens Marijuana is the most widely used illicit drug used by teens today. Approximately 60 percent of the kids who use drugs use only marijuana.

More information

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown)

1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136. Days and Hours: Monday Friday 8:30a.m. 6:00p.m. (305) 355 9028 (JMH, Downtown) UNIVERSITY OF MIAMI, LEONARD M. MILLER SCHOOL OF MEDICINE CLINICAL NEUROPSYCHOLOGY UHEALTH PSYCHIATRY AT MENTAL HEALTH HOSPITAL CENTER 1695 N.W. 9th Avenue, Suite 3302H Miami, FL. 33136 Days and Hours:

More information

WHAT S YOUR ALCOHOL IQ? Excepted from The Beverage Operator s Survival Guide by Robert Plotkin Pages: 85-92

WHAT S YOUR ALCOHOL IQ? Excepted from The Beverage Operator s Survival Guide by Robert Plotkin Pages: 85-92 Test WHAT S YOUR ALCOHOL IQ? Excepted from The Beverage Operator s Survival Guide by Robert Plotkin Pages: 85-92 True/False 1. A frozen Margarita has the same alcohol potency as a Margarita served on the

More information

RANGER COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM (DAAPP)

RANGER COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM (DAAPP) RANGER COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM (DAAPP) DRUG AND ALCOHOL FREE ENVIRONMENT In keeping with the requirements of the US Department of Education s Drug Free Schools and Communities

More information

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction

More information

Cannabis-Marijuana: Addiction,Treatment and Recovery

Cannabis-Marijuana: Addiction,Treatment and Recovery 2006 Cannabis-Marijuana: Addiction,Treatment and Recovery Published By Caron Treatment Centers 1 www.caron.org About Caron Treatment Centers Table of Contents Caron Treatment Centers is a leading provider

More information

Nurses Self Paced Learning Module on Pain Management

Nurses Self Paced Learning Module on Pain Management Nurses Self Paced Learning Module on Pain Management Dominican Santa Cruz Hospital Santa Cruz, California Developed by: Strategic Planning Committee Dominican Santa Cruz Hospital 1555 Soquel Drive Santa

More information

f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH

f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH The American College of Obstetricians and Gynecologists f AQ FREQUENTLY ASKED QUESTIONS FAQ065 WOMEN S HEALTH It s Time to Quit Smoking What are the dangers of smoking? How does smoking affect the body?

More information

BASIC INFORMATION ABOUT ALCOHOL & CONTROLLED SUBSTANCES

BASIC INFORMATION ABOUT ALCOHOL & CONTROLLED SUBSTANCES BASIC INFORMATION ABOUT ALCOHOL & CONTROLLED SUBSTANCES ALCOHOL Section 382.601(b)(11) FMCSR mandates that all employees be provided with training material discussing the effects of alcohol and controlled

More information

Substance Abuse Treatment. Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence

Substance Abuse Treatment. Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence Spring 2007 Volume 6 Issue 1 ADVISORY News for the Treatment Field Naltrexone for Extended-Release Injectable Suspension for Treatment of Alcohol Dependence What is naltrexone for extendedrelease injectable

More information

Care Management Council submission date: August 2013. Contact Information

Care Management Council submission date: August 2013. Contact Information Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing

More information

Residential Sub-Acute Detoxification Guidelines

Residential Sub-Acute Detoxification Guidelines I. Background Information A. Definition of Detoxification Residential Sub-Acute Detoxification Guidelines SAMSA s TIP #45, Detoxification and Substance Abuse Treatment: Treatment Improvement Protocols

More information

MEDICAL POLICY No. 91104-R7 DETOXIFICATION I. POLICY/CRITERIA

MEDICAL POLICY No. 91104-R7 DETOXIFICATION I. POLICY/CRITERIA DETOXIFICATION MEDICAL POLICY Effective Date: January 7, 2013 Review Dates: 1/93, 2/97, 4/99, 2/01, 12/01, 2/02, 2/03, 1/04, 1/05, 12/05, 12/06, 12/07, 12/08, 12/09, 12/10, 12/11, 12/12, 12/13, 11/14 Date

More information

Opioid Treatment Agreement

Opioid Treatment Agreement Opioid Treatment Agreement 1. I understand that my provider and I will work together to find the most appropriate treatment for my chronic pain. I understand the goals of treatment are not to eliminate

More information

Triage, Assessment & Treatment

Triage, Assessment & Treatment Triage, Assessment & Treatment Launette Rieb, MSc, MD, CCFP, FCFP, dip ABAM Clinical Associate Professor, Dept. Family Practice, UBC Physician Director, St. Paul's Hospital Goldcorp Addiction Medicine

More information

Copyright 2011 Pearson Education, Inc. Alcohol and Tobacco

Copyright 2011 Pearson Education, Inc. Alcohol and Tobacco Copyright 2011 Pearson Education, Inc. Alcohol and Tobacco Alcohol: An Overview! 61 percent of Americans consume alcohol regularly.! 25 percent abstain from drinking.! Alcohol and College Students! Approximately

More information

APPENDIX C DRUG FREE WORKPLACE. Employee Substance Abuse and Drug-free Workplace Policy

APPENDIX C DRUG FREE WORKPLACE. Employee Substance Abuse and Drug-free Workplace Policy APPENDIX C DRUG FREE WORKPLACE Employee Substance Abuse and Drug-free Workplace Policy Purpose Employees are Delta s most valuable resource and their health and safety is a serious concern. This agency

More information

Dual diagnosis: working together

Dual diagnosis: working together Dual diagnosis: working together Tom Carnwath RCGP conference Birmingham 2007 DSM-IV & cocaine Cocaine intoxication Cocaine withdrawal Cocaine-induced sleep disorder Cocaine-induced sexual dysfunction

More information

Alcohol: The good, the bad and

Alcohol: The good, the bad and Alcohol: The good, the bad and the Clare Wilhelm, Ph.D. Portland VA Medical Center Oregon Health & Science University Supported by VA Career Development Grant (BX001294) Overview Alcohol statistics the

More information

Information for Pharmacists

Information for Pharmacists Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl

More information

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION

TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment

More information

PREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S.

PREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S. PREVALENCE AND RISK FACTORS FOR PSYCHIATRIC COMORBIDITY IN PATIENTS WITH ALCOHOL DEPENDENCE SYNDROME Davis Manuel 1, Linus Francis 2, K. S. Shaji 3 HOW TO CITE THIS ARTICLE: Davis Manuel, Linus Francis,

More information

Symptom Based Alcohol Withdrawal Treatment

Symptom Based Alcohol Withdrawal Treatment Symptom Based Alcohol Withdrawal Treatment -Small Rural Hospital- Presenter CDR Dwight Humpherys, DO dwight.humpherys@ihs.gov Idaho State University Baccalaureate Nursing Program Lake Erie College of Osteopathic

More information

4 Clinical Particulars

4 Clinical Particulars SUMMARY OF PRODUCT CHARACTERISTICS 1 Name of the Medicinal Product Procyclidine Syrup 5mg/5ml 2. Qualitative and Quantitative Composition Each 5ml dose contains 5mg Procyclidine Hydrochloride BP. 3. Pharmaceutical

More information

FACTSHEET: DUAL DIAGNOSIS

FACTSHEET: DUAL DIAGNOSIS FACTSHEET: DUAL DIAGNOSIS What is dual diagnosis? The term dual diagnosis or dual disorders has in recent years come to be used in the alcohol, drug and mental health fields to describe a particular group

More information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and

More information

COMANCHE NATION COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM 2015-16

COMANCHE NATION COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM 2015-16 COMANCHE NATION COLLEGE DRUG AND ALCOHOL ABUSE PREVENTION PROGRAM 2015-16 Table of Contents Introduction 3 Legal Sanctions Under Local, State, Federal and Tribal Law.. 3 Health Risks Related to Drug and

More information

Identifying and Treating Dual-Diagnosed Substance Use and Mental Health Disorders. Presented by: Carrie Terrill, LCDC

Identifying and Treating Dual-Diagnosed Substance Use and Mental Health Disorders. Presented by: Carrie Terrill, LCDC Identifying and Treating Dual-Diagnosed Substance Use and Mental Health Disorders Presented by: Carrie Terrill, LCDC Overview What is Dual Diagnosis? How Common is Dual Diagnosis? What are Substance Use

More information

Healthy PA: Medicaid Expansion. Ann Bacharach PA Health Law Project February 20, 2014

Healthy PA: Medicaid Expansion. Ann Bacharach PA Health Law Project February 20, 2014 Healthy PA: Medicaid Expansion 1 Ann Bacharach PA Health Law Project February 20, 2014 Healthy PA Medicaid Proposal A waiver proposal to: 2 Make substantial changes PA s existing Medical Assistance program

More information

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents

More information

TREATING ADOLESCENTS

TREATING ADOLESCENTS TREATING ADOLESCENTS A focus on adolescent substance abuse and addiction Center for Youth, Family, and Community Partnerships Presentation developed by: Christopher Townsend MA, LPC, LCAS,CCS, NCC Learning

More information

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation

Advanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a

More information

Are You Considering Medication for Depression?

Are You Considering Medication for Depression? Are You Considering Medication for Depression? Perhaps your counselor or psychiatrist has mentioned this option to you, or you've wondered whether an antidepressant medication might be helpful based on

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

BROADALBIN-PERTH CENTRAL SCHOOL ADOPTED 7/19/04 2 ND READING AND ADOPTION 6/21/10 SUBSTANCE ABUSE

BROADALBIN-PERTH CENTRAL SCHOOL ADOPTED 7/19/04 2 ND READING AND ADOPTION 6/21/10 SUBSTANCE ABUSE BOARD OF EDUCATION ADMINISTRATIVE REGULATION 7.6.1A BROADALBIN-PERTH CENTRAL SCHOOL ADOPTED 7/19/04 2 ND READING AND ADOPTION 6/21/10 Primary Prevention SUBSTANCE ABUSE The intent of primary prevention

More information

White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other.

White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other. Nausicalm Cyclizine hydrochloride Ph. Eur. 50 mg Presentation White, circular, biconvex, uncoated tablets with a score line on one side, plain on the other. Uses Actions The active ingredient-cyclizine

More information

Inpatient Behavioral Health and Inpatient Substance Abuse Treatment: Aligning Care Efficiencies with Effective Treatment

Inpatient Behavioral Health and Inpatient Substance Abuse Treatment: Aligning Care Efficiencies with Effective Treatment Inpatient Behavioral Health and Inpatient Substance Abuse Treatment: Aligning Care Efficiencies with Effective Treatment BHM Healthcare Solutions 2013 1 Presentation Objectives Attendees will have a thorough

More information

Addiction Psychiatry Fellowship Rotation Goals & Objectives

Addiction Psychiatry Fellowship Rotation Goals & Objectives Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction

More information

Development of Chemical Dependency in Adolescents & Young Adults. How to recognize the symptoms, the impact on families, and early recovery

Development of Chemical Dependency in Adolescents & Young Adults. How to recognize the symptoms, the impact on families, and early recovery Development of Chemical Dependency in Adolescents & Young Adults How to recognize the symptoms, the impact on families, and early recovery Tim Portinga, PsyD, LP, Mental Health Clinic Supervisor Tim Portinga

More information

The Science of Addiction and Its Effective Treatment

The Science of Addiction and Its Effective Treatment The Science of Addiction and Its Effective Treatment Anne Arundel County Opioid Misuse and Overdose Symposium April 15, 2015 D. Andrew Tompkins, M.D. M.H.S. Agenda 1. Terminology a. Addiction versus Substance

More information

American Society of Addiction Medicine

American Society of Addiction Medicine American Society of Addiction Medicine Public Policy Statement On Drug Testing as a Component of Addiction Treatment and Monitoring Programs and in other Clinical Settings [Note: ASAM also has a Public

More information

Planning Services for Persons with Developmental Disabilities and Mental Health Diagnoses

Planning Services for Persons with Developmental Disabilities and Mental Health Diagnoses Planning Services for Persons with Developmental Disabilities and Mental Health Diagnoses Persons with Intellectual Disabilities (ID) have mental disorders three to four times more frequently than do persons

More information

Youth Drug Abuse and Addiction

Youth Drug Abuse and Addiction Youth Drug Abuse and Addiction Ken Winters, Ph.D. Dept. of Psychiatry, U. of Minnesota winte001@umn.edu Summit on Prescription Drug Abuse in Georgia March 2, 2011 1. Epidemiology of Rx Abuse by Youth 4.

More information

SACI ALCOHOL AND DRUG ABUSE POLICY

SACI ALCOHOL AND DRUG ABUSE POLICY SACI ALCOHOL AND DRUG ABUSE POLICY Alcohol and Drugs The information in this section of the web site on drug and alcohol use is provided in response to the Drug-Free Schools and Communities Act Amendments

More information

Use of Buprenorphine in the Treatment of Opioid Addiction

Use of Buprenorphine in the Treatment of Opioid Addiction Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary Which of the following is an

More information

The Addicted Brain. And what you can do

The Addicted Brain. And what you can do The Addicted Brain And what you can do How does addiction happen? Addiction can happen as soon as someone uses a substance The brain releases a neurotransmitter called Dopamine into the system that makes

More information

Recovery Resource Packet

Recovery Resource Packet Recovery Resource Packet Colerain Township, Ohio Working together to connect people with the right resources for the assistance they need. COMPANY NAME HERE Addiction Recovery Resources Center for Chemical

More information

ALCOHOL AND DRUG POLICY

ALCOHOL AND DRUG POLICY ALCOHOL AND DRUG POLICY SOWELA is committed to providing a drug free environment for students, visitors, and employees. SOWELA prohibits unlawful possession, use, or sale of any alcoholic beverage or controlled

More information

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services

Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Alternative Benefit Plan (ABP) ABP Cost-Sharing & Comparison to Standard Medicaid Services Most adults who qualify for the Medicaid category known as the Other Adult Group receive services under the New

More information

Chapter 28. Drug Treatment of Parkinson s Disease

Chapter 28. Drug Treatment of Parkinson s Disease Chapter 28 Drug Treatment of Parkinson s Disease 1. Introduction Parkinsonism Tremors hands and head develop involuntary movements when at rest; pin rolling sign (finger and thumb) Muscle rigidity arthritis

More information

Alcohol Withdrawal Syndrome & CIWA Assessment

Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome & CIWA Assessment Alcohol Withdrawal Syndrome is a set of symptoms that can occur when an individual reduces or stops alcoholic consumption after long periods of use. Prolonged

More information

OHIO COUNTY. Demographic Data. Adult Behavioral Health Risk Factors: 2007-2011

OHIO COUNTY. Demographic Data. Adult Behavioral Health Risk Factors: 2007-2011 Prepared by the Department of Health and Human Resources Bureau for Behavioral Health and Health Facilities OHIO COUNTY February 14 Behavioral Health Epidemiological County Profile Demographic Data Ohio

More information

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction.

The Brain, Behavior, and Addiction. Objectives. Advances in science have revolutionized our fundamental views of drug abuse and addiction. The Brain, Behavior, and Addiction Flo Hilliard University of Wisconsin-Madison Division of Continuing Studies Objectives Progress of science in addiction studies Why it is a brain disease Changing our

More information

Not a Harmless Drug: Prevention and Treatment of Marijuana Addiction

Not a Harmless Drug: Prevention and Treatment of Marijuana Addiction Not a Harmless Drug: Prevention and Treatment of Marijuana Addiction Kevin P. Hill, M.D., M.H.S. 10/25/13, Rhode Island Student Assistance Services Conference McLean Hospital Division of Alcohol and Drug

More information

DRIVING HIGH. San Diego County Marijuana Prevention Initiative

DRIVING HIGH. San Diego County Marijuana Prevention Initiative DRIVING HIGH San Diego County Marijuana Prevention Initiative Funded by the County of San Diego, Health and Human Services Agency, Behavioral Health Services MARIJUANA IN AMERICA Legal for medical use

More information